Jump to:
Will guides public companies, investors, and investment banks in securities offerings and strategic transactions. He has extensive experience across industries, including life sciences, healthcare, retail, industrials, and financial services. Clients look to Will for practical and business-focused advice grounded in a deep technical understanding of securities law.
Will advises on a broad range of capital markets transactions, including public and private offerings of equity and debt securities. He is especially skilled at helping companies navigate the IPO process. Will also represents clients on spin offs, tender offers, shareholder activism matters, and mergers and acquisitions. In addition, he represents issuers on a variety of securitization transactions, including whole-business securitizations. As an ongoing part of his practice, Will assists clients on disclosure, trading, stock exchange compliance, and governance issues.
Experience
- Represented Ironwood Pharmaceuticals, Inc. in connection with its spin-off of Cyclerion Therapeutics, Inc., Cyclerion's $175 million private placement, and its $400 million convertible notes offering, as well as shareholder activism matters.
- Represented The Michaels Companies, Inc., a portfolio company of Bain Capital, in multiple 144A bond offerings totaling over $1 billion, its $472 million initial public offering, multiple secondary offerings worth an aggregate total of $2 billion, and its sale in a transaction valued at $5 billion.
- Represented RVL Pharmaceuticals plc, a portfolio company of Avista Capital Partners, in its $68 million initial public offering and private placement and multiple follow-on offerings raising over $100 million.
- Represented BrightSphere Investment Group Inc. in $1.1 billion self-tender offer.
- Represented ImmunoGen, Inc. in multiple follow-on offerings raising over $600 million.
- Represented the underwriters in the $833 million initial public offering and follow-on offerings valued at over $1 billion for Nuvei Corporation.
- Represented the underwriters in the $56 million initial public offering and multiple follow-on offerings totaling over $500 million for CRISPR Therapeutics AG.
- Represented the underwriters in follow-on offerings by Biohaven Ltd. totaling more than $400 million.
- Represented the underwriters in follow-on offerings by Relay Therapeutics raising more than $700 million.
- Represented Dunkin’ Brands Group, Inc. in two secondary offerings totaling over $1.4 billion, its $2.6 billion whole-business securitization and two subsequent refinancings of its whole-business securitization totaling $3.1 billion in fixed rate notes.
- Represented Baring Private Equity Asia as selling shareholder in secondary offerings of Clarivate Plc valued at over $250 million.
- Represented Tiptree Inc. in connection with Warburg Pincus's $200 million investment in Tiptree's subsidiary The Fortegra Group, Inc.
- Represented Servpro Industries, LLC, a portfolio company of The Blackstone Group Inc., in multiple whole-business securitization financings totaling over $1.5 billion.
- Represented Goddard Systems, LLC, a portfolio company of Sycamore Partners, in its $400 million whole-business securitization.
- Represented Frontier Communications in its $1.6 billion offering of fiber network revenue notes.
- Represented Public Service Company of New Hampshire, a subsidiary of Eversource Energy, in its approximately $635 million rate reduction bond offering.
- Represented the Affiliated Managers Group, Inc. in its approximately $480 million forward equity offering.
- Represented Best Doctors Holdings, Inc. in its $440 million sale to Teladoc, Inc.
- Represented the underwriters in offerings by Compass Diversified Holdings of common and preferred equity and 144A bonds raising over $400 million.
- Represented Sigilon Therapeutics, Inc. in its $145 million initial public offering.
- Represented The TJX Companies, Inc. in its $1 billion registered notes offerings and its $1.12 billion notes tender offer.
- Represented Party City Holdco Inc. in its $371 million initial public offering.
- Represented the underwriters in the $214 million initial public offering and the $145 million secondary offering by Multi Packaging Solutions International Limited.
- Represented Civitas Therapeutics, Inc. in its proposed initial public offering, which concluded with its $525 million sale to Acorda Therapeutics, Inc.
- Represented Cabot Corporation in a $300 million registered notes offering.
- Represented Oxford Immunotec Global PLC in its $64 million initial public offering.
- Represented Monitor Company Group Limited Partnership in the successful 363 bankruptcy sale of its business to Deloitte.
- Regularly advises issuers and sales agents in connection with at-the-market offering programs.